Norman S. Miller & Mark S. Gold 
Addictive Disorders in Medical Populations 

This book has a much wider focus than traditional books written
about drug and alcohol addictions. This unique book is written by
medical specialists who diagnose, treat and research addictive
disorders in their specialities. Thus, it meets the needs of the
typical medical practitioner who wants to learn about and treat
patients with addictive disorders in their practices. Because
alcohol and drug problems are so prevalent and affect medical
conditions profoundly, the medical specialist will improve their
knowledge and skill to diagnose and treat addictive disorders in
their specialties.

Drug and alcohol addictions occur commonly in medical
populations; 25-50% of patients seen by primary care
physicians have alcohol and drug disorders, with even higher
prevalence in certain medical specialty populations. Drug use
(including illicit drug use and actual or perceived misuse of
prescribed medications), alcohol use, and what has been called
unhealthy drinking are even more common in trauma centers and our
society. Currently, there are no authoritative addiction texts that
focus on the identification, intervention and management of either
‘addictive disorders in medical populations’ or
‘medical complications in addiction populations’.

Neurobiological progress in the field of addiction has been
amazing and evidence-based treatments have developed at a
phenomenal pace, with bench to office applications for tobacco,
alcohol and drugs. Pharmacological and psychosocial treatments are
described here in detail and in practical terms. The medical and
mental complications of addiction are explained comprehensively
throughout the text. Clinical considerations are the predominant
theme, with the standards of clinical practice grounded in the most
current research. The chapters include practical presentations of
both clinical and research materials, with instruments for
screening and assessment and treatment.

It will be useful for all those seeking information to help a
patient or family with a tobacco, alcohol or drug problem. We hope
this book can give answers and direction to the identification and
management of addictions and their medical complications in patient
populations.

About the author

Dr. Miller has spent 25 years in clinical practice andteaching and research at Cornell University Medical College, the University of Illinois at Chicago; he currently serves as a Clinical Professor at the College of Human Medicine at Michigan State University and works as a psychiatrist at Pine Rest Christian Mental Health Services in Grand Rapids.
He has published 250 medical/scientific articles, book chapters, and reviews, and 12 books on addiction medicine. He is a fellow inthe American Psychopathological Association, and a member of the American Psychiatric Association, the American Society for Addiction Medicine, and the American National Professional Committees. He is a member of the Task Force on Treatment for the Office of National Drug Control Policy, Office of the President ofthe United States; a member of the Center for Substance Abuse Treatment on Screening, Assessment, and Treatment Planning forpatients with Coexisting Mental Illness and Alcohol and Other Drug Abuse; and co-chair of the Task Force for Undergraduate Medical Education, Association for Medical Education and Research ing Substance Abuse. For the American Society for Addiction Medicine, he is Regional Director of the Midwest Region and Editor of Principles of Addiction Medicine (First Edition), Program and Publication Committees. He has coordinated symposia, courses andworkshops for the ASAM annual meeting.

Mark S. Gold, M.D. is an editor, author, teacher, pioneer, researcher and inventor, who has worked for nearly 40years to create models for understanding the effects of tobacco, opiates and other drugs on the brain and behavior. He has developedmodels that have led to the discovery of new addiction treatmentsand has conceptualized novel hypotheses which yielded newapproaches to the definition and treatment of addictions. Dr.Gold’s pioneering work on the brain systems underlying the effectsof opiate drugs led to a dramatic change in the way opiate actionwas understood and his seminal work on cocaine is consideredclassic translational science. Over the past decade, he has definedhedonic overeating as an addiction and developed animal and imagingmodels to develop new treatments for overeating and obesity. Mostrecently, he and his colleagues demonstrated that intravenouslyadministered anesthetics and analgesics are exhaled in the air ofoperating rooms, present on surfaces, and available for second handexposure. Dr. Gold and colleagues have explained the role of theworkplace environment in physician drug abuse, addictions andrelapse after successful treatment. Under his leadership, the Department of Psychiatry at the University of Florida has grown to60 full-time clinical physicians and researchers with new projectsand research groups in secondhand exposure models, functional brainimaging, self-administration, public health, impairedprofessionals, genomics, proteomics and nanotechnology. Dr. Goldhas been awarded numerous national prizes and recognition for hiswork, leadership, and mentoring. Since beginning his career inresearch at the University of Florida in 1970, he has been theauthor of over 900 medical articles, chapters, and abstracts injournals for health professionals on a wide variety of psychiatricresearch subjects and has authored 12 professional books includingpractice guidelines, ASAM core competencies, and medical text booksfor primary care professionals. He is the author of 15 generalaudience books. According to a review in the Journal of the American Medical Association (JAMA 272:18, 1996), ‘Mark S. Gold, M.D. the most prolific and brilliant of the addiction expertswriting today… Dr. Gold has spent his career trying to bridge thegap in medical education and practice with the belief thataddictions are diseases and that all physicians have a criticalrole in prevention and, if that fails, in early identification andprompt treatment.’